Inflammatory Markers Dynamics in Response to Extra-corporeal Membrane Oxygenator Decannulation
试验速览
- 阶段
- 不适用
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Cytokine changes
研究概览
简要总结
Extracorporeal membrane oxygenation (ECMO) aim at providing cardiac, respiratory support, or both. The use of ECMO could be associated with systemic inflammatory response syndrome (SIRS) at the time of initiation or the time of decannulation. There is an existing evidence to state that clinical criteria of SIRS accompany decannulation. We aim at proving this relation through studying the inflammatory markers changes before and after decannulation. The investigators will study all participants who require ECMO support in the heart hospital, all patient will be subjected to clinical evaluation of the SIRS criteria plus studying the inflammatory makers that will include IL1, IL2, IL6 and TNF before and after decannulation. Participants will be divided based on the SIRS criteria into 2 groups and both groups will be compared using Chi-Square analysis (Fisher tests if small sample size) or two tailed t-test, as appropriate
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 70 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •ALL ECMO patients candidates for decannulation
排除标准
- •patients who have identified sepsis prior to decannulation, febrile patients, patient who receive steroids and patient who die within 48 hours after ECMO decannulation.
研究组 & 干预措施
SIRS
Patients will be grouped according to the presence or absence of SIRS criteria into group I (SIRS)
干预措施: Inflammatory makers that will include Interleukins (IL); IL1, IL2, IL6 and TNF (Diagnostic Test)
NON-SIRS
Patients will be grouped according to the presence or absence of SIRS criteria into group II (Non-SIRS)
干预措施: Inflammatory makers that will include Interleukins (IL); IL1, IL2, IL6 and TNF (Diagnostic Test)
结局指标
主要结局
Cytokine changes
时间窗: 2 years
Cytokines changes: Interleukins (IL); IL1, IL2, IL6 and TNF 1 hour before decannulation and 3 times after decannulation (1 hours, 12 hours and 24 hours)
次要结局
未报告次要终点
